Abortion Bans by State 2026

Four years after Dobbs, the US has a starkly divided abortion access map. The 14 states with near-total bans are concentrated in the South and parts of the Midwest: Texas, Alabama, Arkansas, Georgia, Idaho, Kentucky, Louisiana, Mississippi, Missouri, North Dakota, Oklahoma, South Dakota, Tennessee and West Virginia. Several additional states have bans that take effect at 6 or 12 weeks — before most women know they are pregnant. Access-protected states — primarily the Northeast, West Coast and Upper Midwest — have seen surges in providers and patients from ban states.

The legal complexity is significant. Even states with life-of-the-mother exceptions have seen documented cases of women being denied care — physicians are often unclear about when an exception applies, and the threat of prosecution has made many doctors reluctant to perform abortions even in circumstances that appear legally protected. The American College of Obstetricians and Gynecologists has documented multiple cases of women with wanted pregnancies experiencing serious medical complications being denied timely care in ban states because physicians feared legal liability. These cases — which generated national media coverage — have been particularly effective at shifting moderate opinion in ban states.

For women with financial resources, travel across state lines to access abortion care is difficult but feasible. For low-income women — who are overrepresented among abortion patients nationally — travel is often prohibitive. The cost of a procedural abortion, plus travel, accommodation, lost wages and childcare, can total $1,500-3,000 for a woman traveling from rural Texas or Mississippi to a provider in New Mexico or Illinois. Abortion funds and practical support organizations have expanded dramatically since Dobbs, but demand far exceeds available resources.

Medication abortion via mail — using mifepristone and misoprostol, approved by the FDA for up to 10 weeks — has become a primary workaround in ban states. Shield laws in states like Massachusetts, Colorado and New York protect providers who mail medication to patients in ban states. The Trump administration has signaled interest in using federal authority to restrict medication abortion access nationally, which would trigger a significant legal battle. A Supreme Court case challenging FDA approval of mifepristone was dismissed on standing grounds in 2024 but left the underlying regulatory authority unresolved.